As of Aug 27
| +0.12 / +6.45%|
The 4 analysts offering 12-month price forecasts for Synta Pharmaceuticals Corp have a median target of 7.75, with a high estimate of 13.00 and a low estimate of 6.00. The median estimate represents a +291.41% increase from the last price of 1.98.
The current consensus among 5 polled investment analysts is to Buy stock in Synta Pharmaceuticals Corp. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.